Deep learning algorithm (YOLOv7) for automated renal mass detection on contrast-enhanced MRI: a 2D and 2.5D evaluation of results

被引:3
作者
Anari, Pouria Yazdian [1 ]
Lay, Nathan [2 ]
Zahergivar, Aryan [1 ]
Firouzabadi, Fatemeh Dehghani [1 ]
Chaurasia, Aditi [3 ]
Golagha, Mahshid [1 ]
Singh, Shiva [1 ]
Homayounieh, Fatemeh
Obiezu, Fiona [1 ]
Harmon, Stephanie [2 ]
Turkbey, Evrim [1 ]
Merino, Maria [4 ]
Jones, Elizabeth C. [1 ]
Ball, Mark W. [3 ]
Linehan, W. Marston [3 ]
Turkbey, Baris [2 ]
Malayeri, Ashkan A. [1 ]
机构
[1] NIH, Radiol & Imaging Sci Clin Ctr, 10 Ctr Dr,1C352, Bethesda, MD 20892 USA
[2] NIH, Artificial Intelligence Resource, Bethesda, MD USA
[3] NCI, NIH, Urol Oncol Branch, Bethesda, MD USA
[4] NCI, NIH, Pathol Dept, Bethesda, MD USA
基金
美国国家卫生研究院;
关键词
Renal cell carcinoma; Computer vision; YOLOv7; Deep learning; CELL CARCINOMA; ARTIFICIAL-INTELLIGENCE; BIOPSY;
D O I
10.1007/s00261-023-04172-w
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
IntroductionAccurate diagnosis and treatment of kidney tumors greatly benefit from automated solutions for detection and classification on MRI. In this study, we explore the application of a deep learning algorithm, YOLOv7, for detecting kidney tumors on contrast-enhanced MRI.Material and methodsWe assessed the performance of YOLOv7 tumor detection on excretory phase MRIs in a large institutional cohort of patients with RCC. Tumors were segmented on MRI using ITK-SNAP and converted to bounding boxes. The cohort was randomly divided into ten benchmarks for training and testing the YOLOv7 algorithm. The model was evaluated using both 2-dimensional and a novel in-house developed 2.5-dimensional approach. Performance measures included F1, Positive Predictive Value (PPV), Sensitivity, F1 curve, PPV-Sensitivity curve, Intersection over Union (IoU), and mean average PPV (mAP).ResultsA total of 326 patients with 1034 tumors with 7 different pathologies were analyzed across ten benchmarks. The average 2D evaluation results were as follows: Positive Predictive Value (PPV) of 0.69 +/- 0.05, sensitivity of 0.39 +/- 0.02, and F1 score of 0.43 +/- 0.03. For the 2.5D evaluation, the average results included a PPV of 0.72 +/- 0.06, sensitivity of 0.61 +/- 0.06, and F1 score of 0.66 +/- 0.04. The best model performance demonstrated a 2.5D PPV of 0.75, sensitivity of 0.69, and F1 score of 0.72.ConclusionUsing computer vision for tumor identification is a cutting-edge and rapidly expanding subject. In this work, we showed that YOLOv7 can be utilized in the detection of kidney cancers.
引用
收藏
页码:1194 / 1201
页数:8
相关论文
共 24 条
[1]   Role of Imaging in Renal Cell Carcinoma: A Multidisciplinary Perspective [J].
Abou Elkassem, Asser M. ;
Lo, Simon S. ;
Gunn, Andrew J. ;
Shuch, Brian M. ;
Dewitt-Foy, Molly E. ;
Abouassaly, Robert ;
Vaidya, Sandeep S. ;
Clark, Joseph, I ;
Louie, Alexander, V ;
Siva, Shankar ;
Grosu, Anca-Ligia ;
Smith, Andrew D. .
RADIOGRAPHICS, 2021, 41 (05) :1387-1407
[2]  
Anari P. Y., 2023, arXiv
[3]   Advanced magnetic resonance imaging (MRI) of soft tissue tumors: techniques and applications [J].
Bruno, Federico ;
Arrigoni, Francesco ;
Mariani, Silvia ;
Splendiani, Alessandra ;
Di Cesare, Ernesto ;
Masciocchi, Carlo ;
Barile, Antonio .
RADIOLOGIA MEDICA, 2019, 124 (04) :243-252
[4]   Diagnostic Yield and Complication Rate in Percutaneous Needle Biopsy of Renal Hilar Masses With Comparison With Renal Cortical Mass Biopsies in a Cohort of 195 Patients [J].
Cooper, Steven ;
Flood, Trevor A. ;
El Khodary, Mohammed ;
Shabana, Wael M. ;
Papadatos, Demetri ;
Lavallee, Luke T. ;
Schieda, Nicola .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 212 (03) :570-575
[5]   Percutaneous renal mass biopsy: historical perspective, current status, and future considerations [J].
Cotta, Brittney H. ;
Meagher, Margaret F. ;
Bradshaw, Aaron ;
Ryan, Stephen T. ;
Rivera-Sanfeliz, Gerant ;
Derweesh, Ithaar H. .
EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (04) :301-308
[6]   Machine Learning for Medical Imaging1 [J].
Erickson, Bradley J. ;
Korfiatis, Panagiotis ;
Akkus, Zeynettin ;
Kline, Timothy L. .
RADIOGRAPHICS, 2017, 37 (02) :505-515
[7]   Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Escudier, B. ;
Porta, C. ;
Schmidinger, M. ;
Rioux-Leclercq, N. ;
Bex, A. ;
Khoo, V. ;
Grunwald, V. ;
Gillessen, S. ;
Horwich, A. .
ANNALS OF ONCOLOGY, 2019, 30 (05) :706-720
[8]   Diagnostic renal mass biopsy is associated with individual categories of PADUA and RENAL nephrometry scores: Analysis of diagnostic and concordance rates with surgical resection [J].
Fonseca, Ricardo B. ;
Hogan, Melissa M. Straub ;
Kapp, Meghan E. ;
Cate, Frances ;
Coogan, Alice ;
Arora, Sandeep ;
Gordetsky, Jennifer ;
Smelser, Woodson W. ;
Clark, Peter E. ;
Cates, Justin ;
Giannico, Giovanna A. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (06) :371.e7-371.e15
[9]   Deep-Learning-Based CT Imaging in the Quantitative Evaluation of Chronic Kidney Diseases [J].
Fu, Xu ;
Liu, Huaiqin ;
Bi, Xiaowang ;
Gong, Xiao .
JOURNAL OF HEALTHCARE ENGINEERING, 2021, 2021
[10]   THE RICIAN DISTRIBUTION OF NOISY MRI DATA [J].
GUDBJARTSSON, H ;
PATZ, S .
MAGNETIC RESONANCE IN MEDICINE, 1995, 34 (06) :910-914